Abstract:Background: Congenital myopathies are severe genetic diseases with a strong impact on patient autonomy and often on survival. A large number of patients do not have a genetic diagnosis, precluding genetic counseling and appropriate clinical management. Our objective was to find novel pathogenic variants and genes associated with congenital myopathies and to decrease diagnostic odysseys and dead-end. Methods: To identify pathogenic variants and genes implicated in congenital myopathies, we established and conducted the MYOCAPTURE project from 2009 to 2018 to perform exome sequencing in a large cohort of 310 families partially excluded for the main known genes. Results: Pathogenic variants were identified in 156 families (50%), among which 123 families (40%) had a conclusive diagnosis. Only 44 (36%) of the resolved cases were linked to a known myopathy gene with the corresponding phenotype, while 55 (44%) were linked to pathogenic variants in a known myopathy gene with atypical signs, highlighting that most genetic diagnosis could not be anticipated based on clinical-histological assessments in this cohort. An important phenotypic and genetic heterogeneity was observed for the different genes and for the different congenital myopathy subtypes, respectively. In addition, we identified 14 new myopathy genes not previously associated with muscle diseases (20% of all diagnosed cases) that we previously reported in the literature, revealing novel pathomechanisms and potential therapeutic targets. Conclusions: Overall, this approach illustrates the importance of massive parallel gene sequencing as a comprehensive tool for establishing a molecular diagnosis for families with congenital myopathies. It also emphasizes the contribution of clinical data, histological findings on muscle biopsies, and the availability of DNA samples from additional family members to the diagnostic success rate. This study facilitated and accelerated the genetic diagnosis of congenital myopathies, improved health care for several patients, and opened novel perspectives for either repurposing of existing molecules or the development of novel treatments.

Coupling Clinical Exome Sequencing With Functional Characterization Studies To Diagnose A Patient With Familial Mediterranean Fever And Med13l Haploinsufficiency Syndromes

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions

Identification of synonymous pathogenic variants in monogenic disorders by integrating exome with transcriptome sequencing

Implementation of long-read sequencing for routine molecular diagnosis of familial mediterranean fever

A Copernican Revolution of Multigenic Analysis: A Retrospective Study on Clinical Exome Sequencing in Unclear Genetic Disorders

Exome sequencing in undiagnosed congenital myopathy reveals new genes and refines genes-phenotypes correlations

Clinical application of Complete Long Read genome sequencing identifies a 16kb intragenic duplication in EHMT1 in a patient with suspected Kleefstra syndrome

Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease

A patient with homozygous nonsense variants in two Leigh syndrome disease genes: Distinguishing a dual diagnosis from a hypomorphic protein‐truncating variant

The utility of exome sequencing in diagnosing pediatric neurodevelopmental disorders in a highly consanguineous population

Whole-Genome Sequencing in A Patient with Charcot-Marie-Tooth Neuropathy.

Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations

Beyond the exome: what's next in diagnostic testing for Mendelian conditions

PW02-001 - Exome Sequencing for Autoinflammatory Disorders

Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease

The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States

Diagnostic yield of exome sequencing-based copy number variation analysis in Mendelian disorders: a clinical application

Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variants

Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging

Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases